Methylprednisolone showed a marginally significant benefit for aSAH in one study [ 21 ], while corticosteroids were shown to be ineffective or even toxic for TBI and ICH.
← all excerpts
Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis.
1
—
—